Latest Breaking News On - Y mabs therapeutics inc - Page 9 : comparemela.com

Y-mAbs Therapeutics to Present at 42nd Annual J P Morgan Healthcare Conference

Y-mAbs Therapeutics to Present at 42nd Annual J P Morgan Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesCourtney duganMichael rossiCompany quarterly report on formSecurities exchangeCompany annual report on formAssembly disassemblyY mabs therapeutics incGlobe newswirey mabs therapeutics incCompany investor relationsAbs therapeuticsChief executive officerHealthcare conferenceInvestor relationsSelf assembly disassembly

Y-mAbs Therapeutics to Present at 42nd Annual J P Morgan Healthcare Conference

Y-mAbs Therapeutics to Present at 42nd Annual J P Morgan Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesCourtney duganMichael rossiCompany quarterly report on formY mabs therapeutics incAssembly disassemblyCompany annual report on formSecurities exchangeGlobe newswirey mabs therapeutics incCompany investor relationsAbs therapeuticsChief executive officerHealthcare conferenceInvestor relationsSelf assembly disassembly

Landos Biopharma (NASDAQ:LABP) versus Y-mAbs Therapeutics (NASDAQ:YMAB) Financial Survey

Landos Biopharma (NASDAQ:LABP) versus Y-mAbs Therapeutics (NASDAQ:YMAB) Financial Survey
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Memorial sloan kettering cancer centerNew yorkUnited statesLandos biopharmaUniversity hospitals leuvenLandos biopharma incY mabs therapeutics incMassachusetts institute of technologyY mabs therapeuticsGet free reportAbs therapeuticsGiveny mabs therapeuticMassachusetts instituteNucleotide oligomerization domainY mabs therapeutics daily

Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index

Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Courtney duganCompany quarterly report on formSecurities exchangeY mabs therapeutics incGlobe newswirey mabs therapeutics incCompany annual report on formAbs therapeutics addedAbs therapeuticsSecurities actSecurities exchange actAnnual reportQuarterly reportY mabs therapeutics

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) Receives $11 71 Consensus Target Price from Brokerages

Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) have been given an average recommendation of “Hold” by the nine ratings firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and four have given a buy […]

United statesJohan wedell wedellsborgY mabs therapeutics incRice hall james associatesJpmorgan chase coAcadian asset managementConnor clark lunn investment management ltdSecurities exchange commissionMorgan stanleyPrincipal financial group incUnisuper management pty ltdY mabs therapeuticsGet free reportExchange commissionDirector johan wedell wedellsborgAsset management